Stock AXNX AXONICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Axonics, Inc.

Equities

AXNX

US05465P1012

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
66.69 USD +0.23% Intraday chart for Axonics, Inc. -0.39% +7.17%
Apr. 04 Boston Scientific, Axonics Receive FTC Second Request on Merger Deal MT
Apr. 04 Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information DJ

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 940.7 1,987 2,593 3,097 3,153 3,401 - -
Enterprise Value (EV) 1 777.4 1,767 2,372 2,740 2,808 3,041 2,997 3,401
P/E ratio -9.9 x -33.7 x -30.1 x -48.9 x -519 x 132 x 85 x 46.8 x
Yield - - - - - - - -
Capitalization / Revenue 68.1 x 17.8 x 14.4 x 11.3 x 8.61 x 7.59 x 6.37 x 5.32 x
EV / Revenue 56.2 x 15.8 x 13.2 x 10 x 7.66 x 6.79 x 5.61 x 5.32 x
EV / EBITDA -9.79 x -34 x -40.7 x -51.5 x -207 x 45.2 x 38.2 x -
EV / FCF -9.17 x -20.4 x - 2,830 x - 45.1 x 32 x -
FCF Yield -10.9% -4.9% - 0.04% - 2.22% 3.13% -
Price to Book 5.16 x 6.42 x 5.38 x 5.43 x 4.96 x 4.81 x 4.37 x -
Nbr of stocks (in thousands) 33,948 39,809 46,297 49,530 50,662 51,003 - -
Reference price 2 27.71 49.92 56.00 62.53 62.23 66.69 66.69 66.69
Announcement Date 3/4/20 2/25/21 2/24/22 3/1/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 13.82 111.5 180.3 273.7 366.4 448.2 534.4 639.6
EBITDA 1 -79.41 -52.02 -58.27 -53.22 -13.57 67.3 78.44 -
EBIT 1 -80.6 -53.76 -67.39 -64.95 -26.06 8.511 40.98 62.15
Operating Margin -583.21% -48.2% -37.38% -23.73% -7.11% 1.9% 7.67% 9.72%
Earnings before Tax (EBT) 1 -79.93 -54.91 -79.28 -62.32 -8.744 23.54 40.45 71.8
Net income 1 -79.93 -54.92 -80.07 -59.7 -6.088 25.27 37.51 70.74
Net margin -578.39% -49.24% -44.41% -21.81% -1.66% 5.64% 7.02% 11.06%
EPS 2 -2.800 -1.480 -1.860 -1.280 -0.1200 0.5040 0.7850 1.425
Free Cash Flow 1 -84.79 -86.68 - 0.968 - 67.4 93.7 -
FCF margin -613.55% -77.72% - 0.35% - 15.04% 17.53% -
FCF Conversion (EBITDA) - - - - - 100.15% 119.46% -
FCF Conversion (Net income) - - - - - 266.73% 249.79% -
Dividend per Share 2 - - - - - - - -
Announcement Date 3/4/20 2/25/21 2/24/22 3/1/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 46.91 53.14 48.42 68.98 70.38 85.92 70.65 92.89 93.1 109.7 89.78 112.6 113.5 130 110.6
EBITDA 1 -13.81 -15.04 -20.5 -18.54 -13.45 -0.729 -11.55 -8.842 2.567 4.258 -2.892 11.9 10.15 17.8 -
EBIT 1 -16.5 -17.68 -23.53 -21.43 -16.38 -3.609 -14.37 -12.07 -0.687 1.066 -5.05 2.05 1.4 4.35 1.05
Operating Margin -35.18% -33.27% -48.6% -31.07% -23.27% -4.2% -20.33% -12.99% -0.74% 0.97% -5.62% 1.82% 1.23% 3.35% 0.95%
Earnings before Tax (EBT) 1 -16.72 -17.65 -23.78 -21.91 -16.77 0.143 -10.06 -7.646 3.501 5.456 -3.1 7.8 6.4 9.3 6.2
Net income 1 -17.25 -15.17 -22.67 -21.44 -16.25 0.665 -9.248 -7.342 3.928 6.574 -3.74 9.812 7.472 11.73 1.059
Net margin -36.77% -28.54% -46.82% -31.09% -23.09% 0.77% -13.09% -7.9% 4.22% 5.99% -4.17% 8.71% 6.59% 9.02% 0.96%
EPS 2 -0.3800 -0.3400 -0.5000 -0.4700 -0.3400 0.0100 -0.1900 -0.1500 0.0800 0.1300 -0.0960 0.1329 0.1183 0.1757 0.002500
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/24/22 5/5/22 8/1/22 10/31/22 3/1/23 5/1/23 7/27/23 10/30/23 2/28/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 163 220 221 357 345 360 404 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -84.8 -86.7 - 0.97 - 67.4 93.7 -
ROE (net income / shareholders' equity) -49% -23.3% -20.8% -11.3% -1.01% 2.01% 2.87% -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 5.370 7.770 10.40 11.50 12.60 13.90 15.30 -
Cash Flow per Share 2 -2.920 -2.260 - 0.0700 -0.0400 1.320 - -
Capex 1 1.34 2.94 - 2.22 3.55 2.4 2.5 2.6
Capex / Sales 9.69% 2.63% - 0.81% 0.97% 0.54% 0.47% 0.41%
Announcement Date 3/4/20 2/25/21 2/24/22 3/1/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Axonics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
66.69 USD
Average target price
71.8 USD
Spread / Average Target
+7.66%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
AXONICS, INC. Stock Axonics, Inc.
+7.17% 3.4B
STRYKER CORPORATION Stock Stryker Corporation
+12.07% 128B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.04% 10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+0.91% 8.82B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+16.72% 7.19B
GLAUKOS CORPORATION Stock Glaukos Corporation
+25.15% 4.99B
ENOVIS CORPORATION Stock Enovis Corporation
-1.36% 3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-8.73% 2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-10.15% 2B
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-22.81% 1.79B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. AXNX Stock
  4. Financials Axonics, Inc.